Attached files
| file | filename |
|---|---|
| 10-K - ANNUAL REPORT - Citius Pharmaceuticals, Inc. | f10k2018_citiuspharma.htm |
| EX-10.23 - AMENDED AND RESTATED EMPLOYMENT AGREEMENT BETWEEN LEONARD MAZUR AND CITIUS PHARM - Citius Pharmaceuticals, Inc. | f10k2018ex10-23_citius.htm |
| EX-31.2 - CERTIFICATION - Citius Pharmaceuticals, Inc. | f10k2018ex31-2_citius.htm |
| EX-23.1 - CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM - Citius Pharmaceuticals, Inc. | f10k2018ex23-1_citius.htm |
| EX-31.1 - CERTIFICATION - Citius Pharmaceuticals, Inc. | f10k2018ex31-1_citius.htm |
| EX-32.1 - CERTIFICATION - Citius Pharmaceuticals, Inc. | f10k2018ex32-1_citius.htm |
Exhibit 32.2
CERTIFICATION OF CHIEF FINANCIAL OFFICER
PURSUANT TO 18 U.S.C. SECTION 1350
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Annual Report of Citius Pharmaceuticals, Inc. (the “Company”) on Form 10-K for the year ended September 30, 2018 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Jaime Bartushak, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:
| (1) | The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
| (2) | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
| Date: December 11, 2018 | By: | /s/ Jaime Bartushak |
| Jaime Bartushak | ||
| Chief Financial Officer | ||
| (Principal Financial
Officer and Principal Accounting Officer) |